(EMAILWIRE.COM, July 25, 2019 ) The tissue diagnostics market is expected to reach USD 5.14 Billion by 2022 from USD 3.44 Billion in 2016 at a CAGR of 6.9%.

Factors driving the growth of this market include the rising incidence of cancer, growing healthcare expenditure, improving infrastructure for cancer diagnosis, and technological advancements in tissue diagnostics.

In this report, the Tissue Diagnostics market has been segmented based on product, technology, disease, end user, and region.

What the Market Looks Like?
The Report “Tissue Diagnostics Market by Product (Consumables, Instruments), Technology (Immunohistochemistry, in Situ Hybridization, Digital Pathology & Workflow), Disease (Breast Cancer, Gastric Cancer, Lymphoma), End User (Hospital, CRO) - Global Forecast to 2022”

Download a FREE Pdf Brochuer@:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1063949

Consumables are estimated to account for the largest market share in 2017
By product, the tissue diagnostics market is classified into instruments and consumables. The consumables segment is expected to lead the global tissue diagnostics market in 2017. Factors driving the growth of this segment include the wide use of consumables for processing tissue samples, ease of use, and cost-effectiveness.

The immunohistochemistry segment is expected to dominate the market in 2017
By technology, the market is segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. The immunohistochemistry technology segment is expected to account for the largest share of the global tissue diagnostics market in 2017. A large number of products are based on this technology which is a major factor responsible for the dominant share of this segment.

The Major Players Opearting in the Tissue Diagnostics Market:
Key players in the Tissue Diagnostics Market include Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), Merck (Germany), Sakura Finetek Japan (Japan), Abcam (UK), BD (US), QIAGEN (Netherlands), Sienna Cancer Diagnostics (Australia), Royal Philips (Netherlands), A. Menarini Diagnostics (Italy), Cell Signaling Technology (US), Enzo Life Sciences (US), Master Diagnóstica (Spain), TissueGnostics (Austria), Bio SB (US), MedImmune (US), Cernostics (US), Zenalux Biomedical (US), 3DHISTECH (Hungary), Lunaphore Technologies (Switzerland), BioGenex (US), and Biocare Medical (US).

Get a FREE Request Sample Report@:-https://www.marketsandmarkets.com/requestsampleNew.asp?id=9571619

Geographical Detailed Analysis for Tissue Diagnostics Market:
The global tissue diagnostics market is dominated by North America, followed by Europe.
North America will continue to dominate the global market during the forecast period. However, Asia is expected to witness the highest CAGR during the forecast period with growth centered at Japan, China, and India. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the market in this region.